Page last updated: 2024-08-22

thorium and Lymphoma, B-Cell

thorium has been researched along with Lymphoma, B-Cell in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bruland, OS; Dahle, J; Larsen, RH	1

Other Studies

1 other study(ies) available for thorium and Lymphoma, B-Cell

Article	Year
Relative biologic effects of low-dose-rate alpha-emitting 227Th-rituximab and beta-emitting 90Y-tiuexetan-ibritumomab versus external beam X-radiation. International journal of radiation oncology, biology, physics, 2008, Sep-01, Volume: 72, Issue:1 Topics: Alpha Particles; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Beta Particles; Dose-Response Relationship, Radiation; Female; Half-Life; Immunoconjugates; Lymphoma, B-Cell; Mice; Mice, Inbred C3H; Mice, Nude; Radioimmunotherapy; Relative Biological Effectiveness; Rituximab; Thorium; Transplantation, Heterologous; Yttrium Radioisotopes	2008

Article

Year

Relative biologic effects of low-dose-rate alpha-emitting 227Th-rituximab and beta-emitting 90Y-tiuexetan-ibritumomab versus external beam X-radiation.

International journal of radiation oncology, biology, physics, 2008, Sep-01, Volume: 72, Issue:1

Topics: Alpha Particles; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Beta Particles; Dose-Response Relationship, Radiation; Female; Half-Life; Immunoconjugates; Lymphoma, B-Cell; Mice; Mice, Inbred C3H; Mice, Nude; Radioimmunotherapy; Relative Biological Effectiveness; Rituximab; Thorium; Transplantation, Heterologous; Yttrium Radioisotopes

2008